Cigna Group $CI Shares Sold by Candriam S.C.A.

Candriam S.C.A. reduced its position in Cigna Group (NYSE:CI) by 56.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,949 shares of the health services provider’s stock after selling 98,682 shares during the quarter. Candriam S.C.A.’s holdings in Cigna Group were worth $24,778,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the business. Flaharty Asset Management LLC purchased a new stake in Cigna Group during the 1st quarter worth approximately $28,000. 1248 Management LLC acquired a new position in shares of Cigna Group in the first quarter worth $29,000. Solstein Capital LLC purchased a new stake in shares of Cigna Group during the second quarter worth $29,000. Activest Wealth Management increased its position in shares of Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after acquiring an additional 72 shares during the period. Finally, Chilton Capital Management LLC acquired a new stake in shares of Cigna Group in the second quarter valued at $30,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on CI. Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. Wolfe Research reduced their target price on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, October 15th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. JPMorgan Chase & Co. decreased their price objective on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a research report on Tuesday, November 4th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $355.00 target price on shares of Cigna Group in a research note on Friday, October 31st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $334.05.

Cigna Group Trading Down 0.0%

Shares of Cigna Group stock opened at $270.54 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The company has a fifty day simple moving average of $290.47 and a 200-day simple moving average of $301.84. The stock has a market cap of $72.27 billion, a price-to-earnings ratio of 14.77, a PEG ratio of 0.88 and a beta of 0.44. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping the consensus estimate of $7.64 by $0.19. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. During the same period last year, the business earned $7.51 EPS. Cigna Group’s revenue for the quarter was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be given a $1.51 dividend. The ex-dividend date of this dividend is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is 26.64%.

Insider Buying and Selling

In other news, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David Cordani acquired 4,134 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the purchase, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This trade represents a 2.69% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.70% of the company’s stock.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.